Trials / Sponsors / PHARMENTERPRISES LLC

PHARMENTERPRISES LLC

Industry · 11 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis Cystitis	Phase 2	2024-04-01
Completed	Double-blind, Randomized, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Ascendi Healthy Volunteers	Phase 1	2022-09-28
Unknown	Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19 SARS-CoV-2 Infection, Lung Fibrosis	Phase 2 / Phase 3	2022-08-01
Completed	Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumoni SARS-CoV-2 Infection, Fibrosis Lung	Phase 2	2020-09-01
Completed	Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI Influenza, Acute Respiratory Viral Infections	Phase 2	2019-01-31
Completed	Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral I Acute Respiratory Viral Infections, Influenza	Phase 2	2018-02-12
Completed	Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers Influenza, Acute Respiratory Infection	Phase 1	2017-05-22
Completed	XC8 in the Treatment of Patients With Bronchial Asthma Bronchial Asthma	Phase 2	2016-09-20
Completed	XC8 in the Treatment of Patients With Acute Respiratory Viral Infection Influenza, Acute Respiratory Infection	Phase 2 / Phase 3	2016-02-03
Completed	Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers Metabolic Syndrome	Phase 1	2016-01-25
Completed	XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers Asthma	Phase 1	2015-02-14